J
Jayanthi N. Koneru
Researcher at Virginia Commonwealth University
Publications - 81
Citations - 1564
Jayanthi N. Koneru is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 18, co-authored 57 publications receiving 1019 citations. Previous affiliations of Jayanthi N. Koneru include Queen's University.
Papers
More filters
Journal ArticleDOI
Permanent His-bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy: A multicenter experience
Parikshit S. Sharma,Gopi Dandamudi,Bengt Herweg,David Wilson,Rajeev Singh,Angela Naperkowski,Jayanthi N. Koneru,Kenneth A. Ellenbogen,Pugazhendhi Vijayaraman +8 more
TL;DR: Permanent His-bundle pacing may be considered as a rescue strategy for failed BVP and may be a reasonable primary alternative to BVP for CRT.
Journal ArticleDOI
Permanent His-bundle pacing: a systematic literature review and meta-analysis
Francesco Zanon,Kenneth A. Ellenbogen,Gopi Dandamudi,Parikshit S. Sharma,Weijian Huang,Daniel L. Lustgarten,Roderick Tung,Hiroshi Tada,Jayanthi N. Koneru,Tracy L. Bergemann,Dedra H. Fagan,John Harrison Hudnall,Pugazhendhi Vijayaraman +12 more
TL;DR: Permanent cardiac pacing of the His-bundle restores and retains normal electrical activation of the ventricles and improves left ventricular ejection fractions during follow-up.
Journal ArticleDOI
Effect of Catheter Ablation with Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation: The VENUS Randomized Clinical Trial
Miguel Valderrábano,Leif E. Peterson,Vijay Swarup,Paul A. Schurmann,Paul A. Schurmann,Akash Makkar,Rahul N. Doshi,David B. DeLurgio,Charles A. Athill,Kenneth A. Ellenbogen,Andrea Natale,Jayanthi N. Koneru,Amish S. Dave,Irakli Giorgberidze,Hamid Afshar,Michelle L. Guthrie,R.R. Bunge,Carlos A. Morillo,Neal S. Kleiman +18 more
TL;DR: Among patients with persistent AF, addition of vein of Marshall ethanol infusion to catheter ablation, compared with catheter Ablation alone, increased the likelihood of remaining free of AF or atrial tachycardia at 6 and 12 months.
Journal ArticleDOI
Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices.
Frédéric Sacher,Tobias Reichlin,Erica S. Zado,Michael E. Field,Juan F. Viles-Gonzalez,Petr Peichl,Kenneth A. Ellenbogen,Philippe Maury,Srinivas Dukkipati,François Picard,Josef Kautzner,Laurent Barandon,Jayanthi N. Koneru,Philippe Ritter,Saagar Mahida,Joachim Calderon,Nicolas Derval,Arnaud Denis,Hubert Cochet,Richard K. Shepard,Jérôme Corré,James O. Coffey,Fermin C. Garcia,Mélèze Hocini,Usha B. Tedrow,Michel Haïssaguerre,Andre d'Avila,William G. Stevenson,Francis E. Marchlinski,Pierre Jaïs +29 more
TL;DR: Catheter ablation of VT among LVAD recipients is feasible and reasonably safe even soon after LVAD implantation, and intrinsic myocardial scar, rather than the apical cannula, seems to be the dominant substrate.
Journal ArticleDOI
Initial Experience, Safety, and Feasibility of Left Bundle Branch Area Pacing: A Multicenter Prospective Study.
Santosh K. Padala,Vivak Master,Maria Terricabras,Andrea Chiocchini,Aatish Garg,Jordana Kron,Richard K. Shepard,Gautham Kalahasty,Zahara Azizi,Bernice Tsang,Yaariv Khaykin,Alfredo Pantano,Jayanthi N. Koneru,Kenneth A. Ellenbogen,Atul Verma +14 more
TL;DR: LBBA pacing is safe, feasible, and a reliable alternative to His bundle pacing for providing physiological pacing and Randomized controlled studies are needed to confirm the safety, feasibility, and clinical outcomes of LBBAP.